Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Baris Ata

Showing results (1-10 of 215) with videos related to

Pageof 22
Sort By:
Reproductive Biomedicine Online|February 6, 2023
Why ovarian stimulation should be aimed to maximize oocyte yieldBaris Ata
Human Reproduction (Oxford, England)|March 18, 2024
Progestin-primed ovarian stimulation and aneuploidy, innocent until proven guiltyBaris Ata
Human Reproduction Open|August 5, 2025
Why does the recurrent implantation failure literature need to be rewritten?Baris Ata
Reproductive Biomedicine Online|April 26, 2025
Renewing ovarian stimulationBaris Ata
Reproductive Biomedicine Online|February 16, 2024
Response to: Cumulative live birth rate following progestin-primed ovarian stimulation: controversial results with own and donated oocytesBaris Ata, Erkan Kalafat
International Journal of Women'S Health|September 6, 2011
The role of corifollitropin alfa in controlled ovarian stimulation for IVF in combination with GnRH antagonistAyse Seyhan, Baris Ata
Human Reproduction (Oxford, England)|October 16, 2007
Ultrasound guided embryo transfer does not offer any benefit in clinical outcome: a randomized controlled studyBaris Ata, Bulent Urman
Current Opinion in Obstetrics & Gynecology|March 24, 2017
A universal freeze all strategy: why it is not warrantedBaris Ata, Emre Seli
Reproductive Biomedicine Online|August 2, 2025
Response: As with all innovations, it may take a considerable time to change policies - the case of in-vitro maturation (IVM) Safety first, but not necessarily at the cost of effectivenessBaris Ata, Peter Humaidan
Reproductive Biomedicine Online|May 11, 2024
Endometriosis, staging, infertility and assisted reproductive technology: time for a rethinkBaris Ata, Edgardo Somigliana
Pageof 22

Showing results (1-10 of 215) with videos related to

Sort By:
Pageof 22
Reproductive Biomedicine Online|February 6, 2023
Why ovarian stimulation should be aimed to maximize oocyte yieldBaris Ata
Human Reproduction (Oxford, England)|March 18, 2024
Progestin-primed ovarian stimulation and aneuploidy, innocent until proven guiltyBaris Ata
Human Reproduction Open|August 5, 2025
Why does the recurrent implantation failure literature need to be rewritten?Baris Ata
Reproductive Biomedicine Online|April 26, 2025
Renewing ovarian stimulationBaris Ata
Reproductive Biomedicine Online|February 16, 2024
Response to: Cumulative live birth rate following progestin-primed ovarian stimulation: controversial results with own and donated oocytesBaris Ata, Erkan Kalafat
International Journal of Women'S Health|September 6, 2011
The role of corifollitropin alfa in controlled ovarian stimulation for IVF in combination with GnRH antagonistAyse Seyhan, Baris Ata
Human Reproduction (Oxford, England)|October 16, 2007
Ultrasound guided embryo transfer does not offer any benefit in clinical outcome: a randomized controlled studyBaris Ata, Bulent Urman
Current Opinion in Obstetrics & Gynecology|March 24, 2017
A universal freeze all strategy: why it is not warrantedBaris Ata, Emre Seli
Reproductive Biomedicine Online|August 2, 2025
Response: As with all innovations, it may take a considerable time to change policies - the case of in-vitro maturation (IVM) Safety first, but not necessarily at the cost of effectivenessBaris Ata, Peter Humaidan
Reproductive Biomedicine Online|May 11, 2024
Endometriosis, staging, infertility and assisted reproductive technology: time for a rethinkBaris Ata, Edgardo Somigliana
Pageof 22